Stephen Duberley
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
- Intracerebral and Subarachnoid Hemorrhage Research
Papers in
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
-
- Intracerebral and Subarachnoid Hemorrhage Research 3
- Journals
- The Lancet (8 papers)JAMA (5 papers)Nature (2 papers)The Lancet Neurology (1 paper)British Journal of Anaesthesia (1 paper)
- Partner nations
- AustraliaUnited KingdomItaly
In The Last Decade
Stephen Duberley
21 papers receiving 2.7k citations
Stephen Duberley's Hit Papers
Peers
Comparison fields: 5 of 110
- Infectious Diseases 1.3k
- Neurology 690
- Internal Medicine 100
- Applied Microbiology and Biotechnology 52
- Critical Care and Intensive Care Medicine 110
Countries citing papers authored by Stephen Duberley
This map shows the geographic impact of Stephen Duberley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Duberley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Duberley more than expected).
Fields of papers citing papers by Stephen Duberley
This network shows the impact of papers produced by Stephen Duberley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Duberley. The network helps show where Stephen Duberley may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | 2018 | 214 | |
| 6 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 7 | 2021 | 163 | |
| 8 | 2019 | 145 | |
| 9 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 10 | 2022 | 104 | |
| 11 | 2022 | 99 | |
| 12 | 2023 | 83 | |
| 13 | 2019 | 71 | |
| 14 | 2021 | 70 | |
| 15 | 2023 | 56 | |
| 16 | 2023 | 45 | |
| 17 | 2021 | 42 | |
| 18 | 2023 | 34 | |
| 19 | 2021 | 32 | |
| 20 | 2020 | 22 |
About Stephen Duberley
Stephen Duberley is a scholar working on Infectious Diseases, Neurology, Immunology, Rehabilitation and Nutrition and Dietetics, having authored 21 papers that have together received 2.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), interferon and immune responses (2 papers), Diabetes and associated disorders (1 paper), Stroke Rehabilitation and Recovery (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Neurology (690 citations), Internal Medicine (100 citations), Applied Microbiology and Biotechnology (52 citations) and Critical Care and Intensive Care Medicine (110 citations). Stephen Duberley has collaborated with scholars based in Australia, United Kingdom and Italy. Their work appears in journals such as The Lancet, JAMA, Nature, The Lancet Neurology and British Journal of Anaesthesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.